Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-U3212
Periodontal Therapeutics Market is poised to register a CAGR of 8.8% during the forecast period 2022 to 2028. The periodontium is affected by periodontal disease, which is a chronic inflammatory illness. It is one of the two most significant threats to oral health and the most prevalent cause of tooth loss. Periodontal disease, if left untreated, produces chronic inflammation, which leads to insulin resistance, poor glucose tolerance, and a higher risk of diabetes. Diabetes people are more likely than non-diabetic persons to develop periodontitis. Dental health programmes help to build national and local strategies for addressing food and nutrition risk factors for oral illnesses such periodontal disease. Periodontal diseases have a tremendous socioeconomic impact on communities and governments all over the world; nevertheless, due to the disease's low priority, treatment for periodontal diseases is still inaccessible in underdeveloped countries. As the world's population ages, periodontal diseases are growing more widespread, boosting the global market for periodontal therapy. People, on the other hand, have a sloppy attitude toward oral hygiene, which might hurt the market's future growth. The infection of the gums that leads to the development of the periodontal disease can damage the jawbone and destroy it. The inflammation and infection of the gums and bones that surround and support the teeth cause this condition. This condition is primarily caused by poor dental hygiene. Periodontitis can cause tooth loss. Periodontal therapy restores healthy tissues to the mouth. Periodontitis is far more common among people living in developing countries than in developed countries. Treatment varies from professional cleanings that remove calculus and plaque from beneath the gum line to surgical procedures to restore bone tissue and gum. Globally, it is one of the most common oral diseases. With the increasing prevalence of these diseases across the globe, demand for periodontal drugs will continue to soar. Eventually, this would contribute to the growth of the global periodontal therapeutics market. FutureWise Market Research has instantiated a report that provides an intricate analysis of Periodontal Therapeutics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Periodontal Therapeutics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Periodontal Therapeutics Market: • 3M Company • Den-Mat Holdings, LLC • Dexcel Pharma • Kaken Pharmaceutical Co., Ltd. • Oral Science • Valeant Pharmaceuticals International, Inc. • Tolmar Pharmaceuticals • Eli Lilly and Company • Align Technology, Inc. • Glidewell Laboratories • Orapharma • Mallinckrodt Pharmaceuticals • Purdue Pharma L.P • Nobel Biocare Holdings AG • Ultradent Products Inc. • Fibrocell Sciences, Inc • Dentsply International (Note: The list of the major players will be updated with the latest market scenario and trends) Periodontal Therapeutics Market Segmentation: By Product Type • Systemic Antibiotics o Doxycycline o Minocycline o Metronidazole o Others • Local Antibiotics o Arestin o Periochip o Atridox o Others By Type • Gingivitis • Chronic Periodontitis • Aggressive Periodontitis • Necrotizing Periodontal By Distribution Channel • Hospital Pharmacies • Retail Pharmacies • Drug Stores • E-Commerce By Region North America Europe Asia-Pacific Latin America Middle East and Africa Periodontal Therapeutics Market Sample Video: Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the Periodontal Therapeutics Market By Product Type, By Type, By Distribution Channel and By Region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The periodontium is affected by periodontal disease, which is a chronic inflammatory illness. It is one of the two most significant threats to oral health and the most prevalent cause of tooth loss. Periodontal disease, if left untreated, produces chronic inflammation, which leads to insulin resistance, poor glucose tolerance, and a higher risk of diabetes. Diabetes people are more likely than non-diabetic persons to develop periodontitis. Dental health programmes help to build national and local strategies for addressing food and nutrition risk factors for oral illnesses such periodontal disease.
Periodontal diseases have a tremendous socioeconomic impact on communities and governments all over the world; nevertheless, due to the disease's low priority, treatment for periodontal diseases is still inaccessible in underdeveloped countries. As the world's population ages, periodontal diseases are growing more widespread, boosting the global market for periodontal therapy. People, on the other hand, have a sloppy attitude toward oral hygiene, which might hurt the market's future growth.
The infection of the gums that leads to the development of the periodontal disease can damage the jawbone and destroy it. The inflammation and infection of the gums and bones that surround and support the teeth cause this condition. This condition is primarily caused by poor dental hygiene. Periodontitis can cause tooth loss. Periodontal therapy restores healthy tissues to the mouth. Periodontitis is far more common among people living in developing countries than in developed countries. Treatment varies from professional cleanings that remove calculus and plaque from beneath the gum line to surgical procedures to restore bone tissue and gum. Globally, it is one of the most common oral diseases. With the increasing prevalence of these diseases across the globe, demand for periodontal drugs will continue to soar. Eventually, this would contribute to the growth of the global periodontal therapeutics market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Periodontal Therapeutics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Periodontal Therapeutics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Periodontal Therapeutics Market: • 3M Company • Den-Mat Holdings, LLC • Dexcel Pharma • Kaken Pharmaceutical Co., Ltd. • Oral Science • Valeant Pharmaceuticals International, Inc. • Tolmar Pharmaceuticals • Eli Lilly and Company • Align Technology, Inc. • Glidewell Laboratories • Orapharma • Mallinckrodt Pharmaceuticals • Purdue Pharma L.P • Nobel Biocare Holdings AG • Ultradent Products Inc. • Fibrocell Sciences, Inc • Dentsply International (Note: The list of the major players will be updated with the latest market scenario and trends)
Periodontal Therapeutics Market Segmentation: By Product Type • Systemic Antibiotics o Doxycycline o Minocycline o Metronidazole o Others • Local Antibiotics o Arestin o Periochip o Atridox o Others
By Type • Gingivitis • Chronic Periodontitis • Aggressive Periodontitis • Necrotizing Periodontal
By Distribution Channel • Hospital Pharmacies • Retail Pharmacies • Drug Stores • E-Commerce
By Region
Periodontal Therapeutics Market Sample Video:
Competitive Landscape:
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Periodontal Therapeutics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Periodontal Therapeutics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Periodontal Therapeutics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Periodontal Therapeutics Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Systemic Antibiotics 7.1.1. Doxycycline 7.1.2. Minocycline 7.1.3. Metronidazole 7.1.4. Others 7.2. Local Antibiotics 7.2.1. Arestin 7.2.2. Periochip 7.2.3. Atridox 7.2.4. Others 8. Periodontal Therapeutics Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Gingivitis 8.2. Chronic Periodontitis 8.3. Aggressive Periodontitis 8.4. Necrotizing Periodontal 9. Periodontal Therapeutics Market, By Distribution Channel Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospital Pharmacies 9.2. Retail Pharmacies 9.3. Drug Stores 9.4. E-Commerce 10. North America Periodontal Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Periodontal Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Periodontal Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Periodontal Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. 3M Company 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Den-Mat Holdings, LLC 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Dexcel Pharma 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Kaken Pharmaceutical Co., Ltd. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Oral Science 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Valeant Pharmaceuticals International, Inc. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Tolmar Pharmaceuticals 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Eli Lilly and Company 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Align Technology, Inc. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Glidewell Laboratories 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Orapharma 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Mallinckrodt Pharmaceuticals 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Purdue Pharma L.P 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Nobel Biocare Holdings AG 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Ultradent Products Inc. 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Fibrocell Sciences, Inc 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Dentsply International 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Periodontal Therapeutics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Periodontal Therapeutics Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Periodontal Therapeutics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Periodontal Therapeutics Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Systemic Antibiotics 7.1.1. Doxycycline 7.1.2. Minocycline 7.1.3. Metronidazole 7.1.4. Others 7.2. Local Antibiotics 7.2.1. Arestin 7.2.2. Periochip 7.2.3. Atridox 7.2.4. Others
8. Periodontal Therapeutics Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Gingivitis 8.2. Chronic Periodontitis 8.3. Aggressive Periodontitis 8.4. Necrotizing Periodontal
9. Periodontal Therapeutics Market, By Distribution Channel Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Hospital Pharmacies 9.2. Retail Pharmacies 9.3. Drug Stores 9.4. E-Commerce
10. North America Periodontal Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Periodontal Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Periodontal Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Periodontal Therapeutics Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. 3M Company 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Den-Mat Holdings, LLC 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Dexcel Pharma 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Kaken Pharmaceutical Co., Ltd. 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Oral Science 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Valeant Pharmaceuticals International, Inc. 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Tolmar Pharmaceuticals 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Eli Lilly and Company 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Align Technology, Inc. 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10.Glidewell Laboratories 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11.Orapharma 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12.Mallinckrodt Pharmaceuticals 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13.Purdue Pharma L.P 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14.Nobel Biocare Holdings AG 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.15.Ultradent Products Inc. 16.15.1. Company Overview 16.15.2. Product Portfolio 16.15.3. SWOT Analysis 16.15.4. Financial Overview 16.15.5. Strategic Overview 16.16.Fibrocell Sciences, Inc 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17.Dentsply International 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics